- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07825077
Effects of AI Dialogue-Based Scenario Simulation on Students' Flow and Learning Performance
The Effects of Scenario Simulation Via AI Dialogue Integrated With Concept Mapping and Gamified Feedback on Students' Flow and Learning Performance: The Roles of Collaborative Processes and Interaction Mechanisms
This study examines the effects of an AI dialogue-based scenario simulation integrated with concept mapping and post-dialogue feedback on nursing students' learning. Nursing students will participate in pediatric care scenarios using standardized AI-supported dialogues. Two feedback approaches will be compared: gamified feedback and conventional formative feedback without gamification elements. The study will examine students' flow experience and learning performance and explore how collaborative processes and interaction mechanisms may contribute to these outcomes. The findings are expected to provide evidence on how different feedback approaches influence students' engagement and learning during AI-supported scenario simulation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Bao Huan Yang, PhD
- Numéro de téléphone: +88632118999 ext 3401
- E-mail: bhyang@mail.cgust.edu.tw
Lieux d'étude
-
-
Taoyuan City
-
Taoyuan, Taoyuan City, Taïwan, 333324
- Chang Gung University of Science and Technology
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Undergraduate nursing students enrolled in the designated nursing course during the study period.
- Aged 18 years or older.
- Willing to participate and providing informed consent.
Exclusion Criteria:
- Students who decline or do not provide informed consent.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Gamified Feedback Group
Participants receive a concept-mapping-integrated AI dialogue-based scenario simulation followed by gamified feedback. The feedback includes gamification elements such as points, levels, progress indicators, and mission-based features. |
Gamified feedback is delivered following the AI dialogue-based scenario simulation and includes game-related elements such as points, levels, progress indicators, and mission-based features. |
|
Comparateur actif: Conventional Formative Feedback Group
Participants receive the same concept-mapping-integrated AI dialogue-based scenario simulation followed by conventional formative feedback without gamification elements. |
Conventional formative feedback is delivered following the same AI dialogue-based scenario simulation without gamification elements. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Flow Experience
Délai: Baseline (before the intervention) and immediately after completion of the intervention (approximately Week 18).
|
Flow experience will be assessed using the 8-item Flow Experience Questionnaire developed by Pearce et al. (2005). Each item is rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate a greater level of flow experience. Descriptive statistics will be used to examine the distribution and change in flow scores, missing data, and internal consistency. |
Baseline (before the intervention) and immediately after completion of the intervention (approximately Week 18).
|
|
Academic Learning Performance
Délai: At approximately Week 9 (midterm examination) and Week 18 (final examination) of the academic semester.
|
Academic learning performance will be assessed using students' course midterm and final examination scores. Higher scores indicate better academic performance. |
At approximately Week 9 (midterm examination) and Week 18 (final examination) of the academic semester.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Intrinsic Motivation
Délai: Baseline (before the intervention) and immediately after completion of the intervention (approximately Week 18).
|
Intrinsic motivation will be assessed using a 25-item version of the Intrinsic Motivation Inventory (IMI), based on the IMI framework of McAuley et al. (1989) and the version adapted by Yin et al. (2021). Items are rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). The instrument assesses five dimensions: interest/enjoyment, pressure/tension, perceived choice, perceived competence, and perceived value. Reverse-coded items will be recoded before analysis, and each subscale score will be calculated as the mean of its constituent items. |
Baseline (before the intervention) and immediately after completion of the intervention (approximately Week 18).
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- IRB-26-058-B1
- NSTC 115-2410-H-255-014 (Autre subvention/numéro de financement: National Science and Technology Council)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .